Expanding the drug discovery space with predicted metabolite-target interactions.

Expanding the drug discovery space with predicted metabolite-target interactions.
复制标题

通过预测代谢物与目标的相互作用拓展药物发现空间。

DOI:
10.1038/s42003-021-01822-x
复制
发表时间:
2021-03-05
影响因子:
5.9
通讯作者:
Brown JR
Brown JR
中科院分区:
生物学2区
文献类型:
--
作者:
Nuzzo A;Saha S;Berg E;Jayawickreme C;Tocker J;Brown JR

文献摘要

参考文献

被引文献

相似文献

人肠道中产生的代谢产物是已知的宿主免疫调节剂。然而,大规模鉴定代谢物-宿主受体相互作用仍然是一个艰巨的挑战。在这里,我们使用人类微生物组计划2(HMP 2)的炎症性肠病(IBD)队列数据集,采用计算方法识别了983种潜在的代谢物-靶标相互作用。使用多种机器学习方法的共识,我们根据对IBD的重要性对代谢物进行排名,然后进行基于虚拟配体的筛选以识别可能的人类靶点,并从化合物测定、差异基因表达、途径富集和全基因组关联研究中添加证据。我们证实了已知的代谢物-靶标对,如烟酸-GPR 109 a或亚油酰乙醇酰胺-GPR 119,并推断了感兴趣的相互作用,包括油酸-GABRG 2和α-CEHC-THRB。使用人原代细胞类型检测了11种代谢物的体外生物活性。通过扩大可能的微生物代谢物-宿主蛋白质相互作用的范围,我们为潜在的免疫疗法提供了多种药物靶点。Nuzzo等人使用计算方法,从人类微生物组计划2(HMP 2)的炎症性肠病(IBD)队列数据集和公共数据库中确定了983种潜在的代谢物-人类靶标相互作用。这些预测的相互作用可以进一步了解宿主-微生物组相互作用,并有助于IBD和其他疾病的药物发现。
Metabolites produced in the human gut are known modulators of host immunity. However, large-scale identification of metabolite–host receptor interactions remains a daunting challenge. Here, we employed computational approaches to identify 983 potential metabolite–target interactions using the Inflammatory Bowel Disease (IBD) cohort dataset of the Human Microbiome Project 2 (HMP2). Using a consensus of multiple machine learning methods, we ranked metabolites based on importance to IBD, followed by virtual ligand-based screening to identify possible human targets and adding evidence from compound assay, differential gene expression, pathway enrichment, and genome-wide association studies. We confirmed known metabolite–target pairs such as nicotinic acid–GPR109a or linoleoyl ethanolamide–GPR119 and inferred interactions of interest including oleanolic acid–GABRG2 and alpha-CEHC–THRB. Eleven metabolites were tested for bioactivity in vitro using human primary cell-types. By expanding the universe of possible microbial metabolite–host protein interactions, we provide multiple drug targets for potential immune-therapies. Using computational approaches, Nuzzo et al. identify 983 potential metabolite–human target interactions from the Inflammatory Bowel Disease (IBD) cohort dataset of the Human Microbiome Project 2 (HMP2) and public databases. These predicted interactions can further the understanding of host–microbiome interactions and assist in drug discovery for IBD and other diseases.
DOI: 10.4049/jimmunol.1701625
发表时间: 2018-04-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Bhatt B;Zeng P;Zhu H;Sivaprakasam S;Li S;Xiao H;Dong L;Shiao P;Kolhe R;Patel N;Li H;Levy-Bercowski D;Ganapathy V;Singh N
通讯作者: Singh N
DOI: 10.1093/nar/gky1120
发表时间: 2019-01-08
影响因子: 14.9
作者:
Buniello, Annalisa;MacArthur, Jacqueline A. L.;Parkinson, Helen
通讯作者: Parkinson, Helen
DOI: 10.1016/j.cell.2016.10.042
发表时间: 2016-11-17
期刊: CELL
影响因子: 64.5
作者:
Astle, William J.;Elding, Heather;Soranzo, Nicole
通讯作者: Soranzo, Nicole
DOI: 10.1016/j.cell.2018.07.038
发表时间: 2018-08-09
期刊: Cell
影响因子: 64.5
作者:
Fischbach MA
通讯作者: Fischbach MA
DOI: 10.1111/j.2517-6161.1995.tb02031.x
发表时间: 1995-01-01
影响因子: 5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者: HOCHBERG, Y